Citius Oncology, Inc. SEC filings CTOR

Citius Oncology, Inc. has 268 filings in SEC EDGAR's recent list, going back to May 19, 2021. Its latest annual report, Form ARS, was filed on Aug 26, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on September 30.

Form Description Filed Period
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
10-Q Quarterly report Feb 13, 2026 Dec 31, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
10-Q Quarterly report Feb 14, 2025 Dec 31, 2024
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
10-Q Quarterly report May 20, 2024 Mar 31, 2024
10-Q Quarterly report Nov 20, 2023 Sep 30, 2023
10-Q Quarterly report Aug 16, 2023 Jun 30, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
10-Q Quarterly report Nov 28, 2022 Sep 30, 2022

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CTOR (Nasdaq)
Fiscal year ends
September 30
Incorporated in
DE
Headquarters
Cranford, NJ
SEC filer status
, Emerging growth company
SEC CIK
1851484
Former names
TenX Keane Acquisition (until Aug 5, 2024)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.